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14 Each year, more than 40,000 craniotomies are performed for tumor resection or for craniocervical trauma. During surgery, the brain parenchyma, resection cavity, and subarachnoid spaces are routinely irrigated with 0.9% normal saline. Gelfoam is frequently soaked in saline or thrombin and left in resection cavities to facilitate hemostasis. Normal saline as well as Gelfoam are considered nontoxic; however, results of our culture studies indicated that neuronal survival may be suboptimal after these surgical maneuvers. It would be extremely helpful to use, at the time of surgery, an irrigating solution with neurotrophic capabilities that would also minimize neurotoxic reactions.
We reasoned that the nutritional requirements of traumatized brain might be similar to those required to initiate growth of neuron cells in culture, because such cultures begin with a process of traumatic extraction of cells from brain tissue. To reduce degeneration and achieve regeneration of these isolated cells, we empirically optimized 28 components of the Neurobasal/B27 medium to promote survival of embryonic rat hippocampal neurons after 4 days in culture. 5 This medium contains nine common salts; eight common vitamins; 18 common amino acids (with omission of excitotoxic glutamate and aspartate); glucose; pyruvate; four lipid precursors and a lipid carrier (choline, ethanolamine, two essential fatty acids, and carnitine); and three sugars (glucose, galactose, and inositol). In addition, five antioxidants (catalase, superoxide dismutase, vitamin E, vitamin E acetate, and glutathione); five hormones; and three other components (transferrin, putrescine, and albumin) were each found to improve neuron survival at optimal concentrations. With further modification of osmolarity and addition of the gonadal steroid precursor DHEAS, this culture medium also promoted regeneration of axons and dendrites in adult rat 1 and human neuron cultures. 3 These media are based on a bicarbonate buffering system suitable for an incubator with 5% CO 2 . Neuregen-D is a version of this medium that contains DHEAS and human albumin 3 in place of bovine albumin; it may be useful to promote regeneration of well-perfused brain lesions at 5% CO 2 .
In the process of isolation of neurons for cell culture, brain tissue is exposed to ambient levels of CO 2 (0.2%), which results in the detrimental alkalinization of CO 2 -dependent media. 4 This is comparable to conditions occurring during brain surgery, including poor perfusion adjacent to the lesion, and also exposes tissue to ambient CO 2 . Therefore, Hibernate medium was developed to buffer pH more effectively at ambient levels of CO 2 while providing the same nutrient support. 4 Neuregen-I is similar to Hibernate, with the addition of DHEAS and human albumin 3 in place of bovine albumin. These changes may be useful to protect against degeneration in poorly perfused brain lesions. In this paper, we test the hypothesis that providing nutrients in vivo that promote regeneration of neurons in culture is superior to irrigation with saline for minimizing neurodegeneration in a model brain lesion consisting of cortical aspiration and transection of the rat fimbria-fornix area. 17 This model was chosen for the following features: 1) its relative reliability for deafferentation of the medial septum; 2) the circumscribed lesion in the cortex suitable for quantitative analysis; 3) the potential for comparison to the application of another culture medium, DMEM; and 4) relative to a single injection, the prolonged resident time of the test agent applied in Gelfoam implanted into the cavity lesion. In this model, we also evaluated whether a CO 2 -dependent (Neuregen-D) or CO 2 -independent (Neuregen-I) medium better reduces degeneration and gliosis adjacent to the lesion. Last, we determined whether the neurotrophic factor bFGF, which has previously been shown to be efficacious with another nutrient medium, DMEM, 17 could boost survival.
Materials and Methods

Neuron Culture
Neurons from embryonic Sprague-Dawley rat hippocampus were cultured in serum-free Neurobasal, 2% B27, and 0.5 mM glutamine (GIBCO/Invitrogen, Carlsbad, CA) in 5% CO 2 , and 9% O 2 .
5 Briefly, hippocampi from embryonic Day 18 Sprague-Dawley rats were mechanically disrupted into a single cell suspension and plated at 16,000 cells/cm 2 on plastic substrate that had been coated with polylysine. Full medium changes to 0.9% saline, Neuregen, or other solutions were made after 5 days of culture, followed by continued culture at 37˚C in ambient CO 2 (0.2%). Krebs buffer contains 100 mM NaCl, 20 mM KCl, 1 mM MgCl 2 , 1 mM CaCl 2 , 1 mM NaH 2 PO 4 , 4.2 mM NaHCO 3 , 10 mM glucose, 12.5 mM 4-(2-hydroxyethyl)-1-piperazine-ethanesulfonic acid (pH 7.3). The DMEM was obtained from GIBCO/Invitrogen, and the B27 supplement was added at 2%. Survival was evaluated with the aid of fluorescence microscopy by counting individual cells that hydrolyzed and retained fluorescein diacetate (live cells) or stained with propidium iodide (dead cells). 5 Survival was calculated as 100 ϫ live cells/(live ϩ dead cells).
Animal Preparation
Six adult male Sprague-Dawley rats weighing 350 to 374 g (mature: 3 months old) were used for each study group (Harlan, Indianapolis, IN). Animals were housed at our university's animal facility at 23 Ϯ 1˚C with 40 to 60% relative humidity and a 12-hour light/ dark cycle; food and water were freely available. Two to four surgeries were performed per day, with different test agents given so that the experience was randomized with respect to treatment. The six treatment groups included the following: 1) saline; 2) Neuregen-I; 3) Neuregen-D; 4) Neuregen-I plus bFGF; 5) DMEM plus bFGF; and 6) sham (no lesion, craniotomy only). One rat was added to replace one that died within 2 to 15 hours after surgery in each of the following groups: saline, Neuregen-I, and Neuregen-I plus bFGF. No other animals died or displayed morbidity during the 4-week treatment period.
On the day of surgery, animals were anesthetized with a combination of ketamine (86 mg/ml) and xylazine (4.5 mg/ml) (Fort Dodge Animal Health, Fort Dodge, IA) given intraperitoneally at 1 ml/kg. The rat's head was shaved, cleaned with a povidone-iodine solution, and then secured in a Kopf stereotactic apparatus (Kopf Instruments, Tujunga, CA). The abdomen and joint areas were padded and supported with paper towels. The skin over the skull was incised at the midline and separated with retractors; hemostasis was achieved with a disposable cautery (Bergen Brunswig, Orange, CA). Cortical aspiration and fimbria-fornix lesions were completed according to the method of Otto, et al. 17 After identification of the bregma and coronal suture, the right fimbria-fornix area and supracallosal striae were targeted using stereotactic coordinates from Paxinos and Watson, 18 modified by experience with 3-month-old rats: anteroposterior Ϫ2.1 mm from bregma, lateral Ϫ2 mm from midline, and vertical Ϫ6 mm.
The overlying skull was trephinated to a 2-mm-diameter circle with a 1.2-mm-diameter electric drill bit (no. 106 engraving cutter; Dremel, Racine, WI) and the meninges were coagulated and opened. The cortex covering the right hippocampus was removed by aspiration with a 1-mm-diameter suction tip (V. Mueller; Allegiance Healthcare, McGaw Park, IL). Complete transection of the right fimbria-fornix area and supracallosal striae down to the level of the white matter was performed with a scalpel blade under visual control aided by a surgical microscope. The surgical transection was located close to the rostral end of the septal pole of the hippocampus. Completeness of the transection was assured by aspirating the fimbria-fornix area; sham treatment involved craniectomy without aspiration. A sterile piece of Gelfoam measuring 3 ϫ 5 ϫ 5 mm was saturated with 30 l of test medium and placed in the cortical lesion cavity (Neuregen was formulated in our laboratory from ingredients supplied by Sigma-Aldrich Chemical Co. [St. Louis, MO] and is available by special order from http://www.siumed.edu/brainbits). The surgeon was blinded to the identity of the test medium. The scalp wound was closed with surgical staples and infection was inhibited by topical application of Neosporin.
Analysis of Neuron and Glial Densities
Four weeks postsurgery, a time of maximal cell loss in the medial septum, 9 animals were anesthetized with 80 mg/kg Nembutal (Abbott Laboratories, Chicago, IL) and the abdomen was opened for transcardial perfusion. After perfusion with 0.9% saline and 4% paraformaldehyde in 0.1 M Na phosphate (pH 7.4), the brain was removed, blocked, and embedded in paraffin. Ten-micrometer sections cut through the lesion or the equivalent region (sham treatment) were stained with cresyl violet or anti-GFAP antibody.
The GFAP immunostaining was accomplished in parallel by deparaffinizing sections three times for 10 minutes with xylene and rehydrating two times each with 100% ethanol, 95% ethanol, and 70% ethanol, followed by water. Endogenous peroxidase was blocked for 30 minutes in 0.5% H 2 O 2 in methanol. Nonspecific antibody binding was inhibited with 5% dried milk and cells were permeabilized in 0.1% Triton X-100 in phosphate-buffered saline (diluent). Rabbit anti-bovine GFAP (Dako Corp., Carpinteria, CA) was diluted 1:800 and added to sections, which were incubated for 15 hours at 4˚C. After rinsing, bound antibodies were labeled by incubation for 1 hour at 22˚C with a 1:80 dilution of goat anti-rabbit/IgG peroxidase conjugate. Bound peroxidase was detected after rinsing by incubation for 15 minutes with 0.05% diaminobenzidine in 0.01% H 2 O 2 ; control cultures lacked primary antibody. Staining was imaged in 540 ϫ 690-m areas with a Spot digital charge-coupled device camera (Diagnostic Instruments, Sterling Heights, MI) under constant illumination and evaluated for mean staining density with commercially available software (Image Proϩ; Media Cybernetics, Silver Spring, MD). No systematic changes in background were seen among treatment groups. Density (darkness) was converted from intensity (brightness) by subtraction: 255 Ϫ intensity. The GFAP density is the mean pixel darkness (staining intensity) within the stated area. The evaluator was blinded to treatment condition.
Coronal 10-m sections were selected at 100-m intervals through the 1.5-mm diameter of the lesion, and stained with cresyl violet. Sections were imaged with a ϫ20 objective lens (total magnification ϫ1000) and evaluated for neuron counts in a 100 ϫ 1800-m area adjacent to the lesion cavity (Fig. 1) . The 1800-m depth included cortical Layers I through IV in a volume of 10 ϫ 100 ϫ 1800 m (1.8 ϫ 10 6 m syl violet-stained cells with one or two darker nucleoli were counted as neurons. Because nucleoli are only 2 m in diameter, it was not necessary to correct for counting bias in the size of the cells. The mean counts from two sections separated by at least 100 m were used as an estimate of cell density for each animal. Equivalent areas contralateral to the lesion were similarly evaluated by translocation of the Neurolucida template.
Statistical Analysis
Results are presented as the means Ϯ SEM. Results between pairs of groups were evaluated for statistical significance by using multifactor ANOVA, with distance from the lesion being a within-group factor (split plot) that was calculated using Plotit software (Scientific Programming Enterprises, Haslett, MI) or statistical software from SAS Institute, Inc., Cary, NC. For neuron densities in the medial septum, the Student t-test was applied to compare saline treatment and other groups. The null hypothesis, that two groups were statistically indistinguishable, was rejected at a probability value of less than 0.05.
Results
Neurons in Saline and Ambient CO 2
To evaluate the effect of saline on neurons, 5-day-old embryonic neuronal cultures were treated with 0.9% saline for 24 or 48 hours. Figure 2 shows significant loss of neuron viability after incubation in saline for 24 hours, as judged by retention of fluorescein and exclusion of propidium iodide. While technically still alive, many neurons displayed retracted dendrites (data not shown), a process that was exacerbated after 48 hours. Krebs buffer, which contains salts, glucose, and a pH buffer, produced higher survival rates than saline (86% of control cells left in 5% CO 2 ). Nevertheless, because survival rates were higher at both 24 and 48 hours for Neuregen-I, which contains additional components, this medium was chosen. After incubation in Neuregen-I for 24 hours, neuron survival was 100% of control cells in 5% CO 2 . Table 1 lists the composition of Neuregen-I, which was designed for poorly perfused tissue to provide pH buffering with 3-(N-morpholino)-propane sulfonate in place of 26 mM bicarbonate, which is more appropriate for well-perfused brain tissue or a CO 2 incubator. This nutrient solution contains common salts, 18 nonexcitatory amino acids, eight vitamins, six other nutrients, and five lipid precursors crucial for regeneration of membranes. Neuregen-I also contains six hormones, including DHEAS, which has been shown to aid in trophic support of neurons 3, 19 and five antioxidants likely to be protective against the O 2 radicals produced in injured tissue. 5 The DMEM and Neuregen-D were not supportive of neuron survival compared with Neuregen-I because of the rapid rise in pH to above 8 within 3 hours in ambient CO 2 (0.2%). 4 The buffering of pH is not the only reason for the benefit of Neuregen-I; Krebs solution is also appropriately buffered for ambient CO 2 , but its lack of amino acids and other components caused reduced survival in vitro (Fig. 1) . In summary, neuron survival in ambient CO 2 was best with Neuregen-I (in descending order: Neuregen-I Ͼ Krebs solution Ͼ saline Ͼ DMEM/ B27 = Neuregen-D).
Neurodegeneration Distant From a Cortical Aspiration Lesion Decreases With Neuregen-I
In a rat cortical aspiration lesion model, we evaluated neuron survival 4 weeks postsurgery as a function of distance from the lesion cavity (Fig. 1) . In coronal sections, subsection rectangular areas were evaluated as indicated for both absolute neuron densities and density relative to the contralateral unlesioned side. Photomicrographs of the first 100 m from the edge of the lesion (Fig. 3A and B) show higher cell survival with Neuregen compared with saline. We measured the diameters of 100 neurons within 100 m of the lesion edge after 4 weeks of treatment. 
Evaluation of the Contralateral Cortex
Treatments were also evaluated as a percentage of neuron density in the corresponding region of the nonlesioned contralateral cortex. We found that lesions treated with Neuregen-D were no different from those treated with saline (Fig. 5 upper) . Although treatment with Neuregen-I compared with saline treatment resulted in 15% higher neuron densities on the unlesioned side compared with the lesioned side over the middle distances of 200 to 400 m, the increase was not significant (F[1,10] = 3.2, p = 0.1). The absolute measures of neuron density on the side contralateral to the lesion are shown in Fig. 5 lower. A significant decrease in neuron density on the contralateral side was found 
Neuregen-I Plus bFGF is More Protective Than DMEM Plus bFGF Around a Cortical Lesion
Otto, et al., 17 showed neuroprotection in the medial septum after a lesion in the fimbria-fornix area was treated with Gelfoam soaked in DMEM plus bFGF (10 ng/ml). In the rat brain, we compared treatment with DMEM plus bFGF to Neuregen-I plus bFGF at a distance from the cortical lesion (Fig. 6 ). Although treatment with DMEM plus bFGF showed a trend toward improvement at a distance from the cortical lesion, the findings did not reach significance with only six animals in the group (F[1,10] = 3.9, p = 0.08). More importantly, treatment of the lesion cavity with Neuregen-I plus bFGF resulted in a 50% increase in cell density above that seen with saline (p = 0.002) and was significantly higher than sham treatment as a function of the interaction of treatment and distance (F[5,45] = 2.9, p = 0.02). Therefore, we contend that ingredients in Neuregen provide better neuroprotection than those in DMEM (F[1,10] = 6.2, p = 0.03).
Increased neuron density for Neuregen-I plus bFGF compared with sham treatment is also supported by measures on the contralateral side ( Fig. 5B ; F[1,10] = 7.4, p = 0.02). Based on the image in Fig. 3C , we suggest that this increase may be due to smaller neurons in the area, a finding substantiated by measurements reported in Table 2 . A similar reduction in size was observed for adult neurons that multiply in culture in the presence of bFGF. 2 
Inhibition of Gliosis Around a Cortical Lesion
Lesions in the CNS result in gliosis, an activation of astroglia to produce cytokines and deposit extracellular matrix as part of an inflammatory response.
11 Because Neurobasal/B27 medium was shown to inhibit the proliferation of astroglia in culture, 5 possibly because of its corticosterone content, 6 Neuregen was evaluated for its effect on induction of GFAP, the intermediate filament marker for astroglia. For saline treatment, immunostaining for GFAP persisted for 4 weeks postlesioning, with the most pronounced labeling at the edge of a cortical aspiration lesion; labeling declined with distance from the lesion (Fig. 7A) . In contrast, GFAP immunoreactivity was virtually absent in lesions treated with Neuregen-I (Fig. 7B) . The mean stain densities for lesions from three animals showed that addition of Neuregen-I or -D resulted in GFAP densities that were no different from those seen after sham treatment, but significantly less than with saline treatment ( Fig. 8; F[1,25] = 12.4, p = 0.002). These results demonstrate that Neuregen inhibits the gliosis that occurs after saline treatment of a cortical lesion.
Benefits of an Optimized Nutrient Medium for Survival of Axotomized Neurons of the Medial Septum
Axons in the lesioned fimbria-fornix area terminate in the medial septum. The same treatments that were evaluated earlier for cortical neuron survival were evaluated in the deafferented medial septum by counting cresyl violetstained neurons. Figure 9 shows a 55% increase in neuron density for Neuregen-I treatment relative to saline (t-test, p = 0.02), and neuron density after treatment with Neuregen-I approaches that seen in sections of sham-treated (unlesioned) brain. The other treatments were also significantly better than saline, but not significantly better than Neuregen-I.
Discussion
A nutrient medium optimized for survival of neurons in culture appears to benefit lesions produced in vivo. One month after a cortical aspiration lesion, the superior neuropreservation found with a Gelfoam implant soaked in this nutrient medium indicates that nutrient support surrounding the lesion is compromised and that saline treatment contributes to neurodegeneration. The common surgical practice of irrigating the brain parenchyma, resection cavity, and subarachnoid spaces with normal saline may be detrimental Each point is the mean Ϯ SEM for neuron density in six animals in an area of 100 ϫ 1800 m as a function of distance from the edge of the lesion. Probabilities were determined using two-factor ANOVA against saline.
to cell survival. Based on preparatory studies in culture, exposure to a buffered salt solution such as Krebs-Ringer solution for 24 hours also fails to support neuron survival (Fig. 2) .
For lesions treated with Neuregen-I, neuron densities at a distance from the lesion are nearly equal to sham lesions and 25% higher than with saline treatment. Neuregen-I also preserves neuron density of axotomized neurons in the medial septum. Neuron densities contralateral to the lesion are also 20 to 35% higher with Neuregen-I than with saline and are higher than with Neuregen-D relative to the lesioned side. For saline, contralateral loss of neurons from interhemispheric deafferentation or changes in neuropil induced by the lesion may be responsible for some of these differences. Our results are consistent with the findings of Jones 12 in untreated sensorimotor cortical lesions, in which the contralateral neuropil expanded to produce a decrease in neuron density. Such expansion may provide some recovery of function from the loss of ipsilateral neurons, but minimizing the loss around the lesion would be preferable.
Comparison of CO 2 -Independent With CO 2 Dependent Medium
Direct comparisons of the CO 2 -independent medium, Neuregen-I, with CO 2 -dependent Neuregen-D in brain lesions showed a trend toward superiority of Neuregen-I that did not reach statistical significance with only six animals in the groups (Figs. 4 and 5A ). Poorly perfused brain tissue around a lesion may not require Neuregen-I for buffering pH when the lesion size is small and exposure to ambient CO 2 only lasts for a few minutes as in our studies. Clearly, longer periods in ambient CO 2 in culture are detrimental with Neuregen-D (Fig. 2) . The usual storage conditions for Neuregen-D do not control the CO 2 concentration, which leads to alkalinization, whereas the pH of Neuregen-I is stable. Therefore, we prefer the handling properties of and treatment with Neuregen-I.
Evidence of Gliosis
There is evidence that the gliosis accompanying CNS lesions is both deleterious and beneficial; it is associated with the release of both neurotoxins and neurotrophins. 8 A simple stab wound into the rat cortex results in a spreading gliosis to the entire hemicortex. 13 Because we observed profuse gliosis associated with neuronal loss in lesions treated with saline, and gliosis is reduced to levels seen in shamtreated rats with Neuregen treatments, then either the neurodegeneration could cause the gliosis or vice versa. Either way, formation of a glial scar is widely viewed as non- permissive to axon regeneration. The reduction in glial scarring by Neuregen-I may be due to the corticosterone content, which has been shown to reduce glial proliferation in culture. 5, 6 This inference could be explicitly tested in our lesion model by omission of corticosterone from the nutrient mixture.
Is one Nutrient Medium as Good as Another?
In other brain lesion and graft studies DMEM has been used as a vehicle, sometimes with bFGF. 10, 16, 17 The ingredients in Neuregen provided greater neuroprotection than those in DMEM in the neocortex. On the side contralateral to the cortical lesion, treatment with Neuregen-I plus bFGF produced a 16% increase in neuron density relative to Neuregen-I treatment (p = 0.02). Whether this represents neurogenesis to replace lost neurons from the lesion needs to be determined by labeling with bromodeoxyuridine. Neuregen-I plus bFGF was no better than Neuregen-I alone in preserving neuron density in the medial septum. These results emphasize the benefits of Neuregen-I to axotomized pathways. In the medial septum, DMEM caused total neuron cell loss, 17 whereas we observed only a 20% loss for Neuregen-I.
The failure of bFGF to provide additional benefits could be due to its degradation, but bFGF was of significant benefit after 4 weeks in the experiments of Otto, et al. Aside from some small differences in amino acid and salt concentrations compared with DMEM, Neuregen has the amino acids alanine and asparagine, vitamin B 12 , ZnSO 4 , two fatty acids, eight vitamins, nine other components (including a different buffer), six hormones, and five antioxidants. In addition, the osmolarity of Neuregen was optimized for isolation of adult neurons at 260 mOsm, 1 whereas DMEM has an osmolarity of 340 mOsm for growth of polyoma virus in fibroblasts. 7, 15 The optimization of Neuregen that was achieved in culture appears beneficial in vivo. One disadvantage of such a nutrient medium is that it would be impractical to optimize in vivo each of the 59 common salts and nutrients. For evaluation of trophic factors and cell grafts, however, the combined nutritive ingredients in Neuregen could make it a superior vehicle to saline or DMEM.
Future Studies
Because the components of Neuregen are common salts and nutrients that support neuron viability in culture, their beneficial effects on neuron survival after cortical lesion bodes well for further studies involving behavioral models of CNS injury and restoration of function. The effect of Neuregen on behavioral recovery from a motor cortex or spinal cord lesion would provide quantitative analysis of this important issue. The ability of a similar medium to promote regeneration of human neurons in culture 3 should further encourage preclinical studies to monitor adverse effects during treatment, as well as the duration of nutrient integrity and volumes of distribution in rat and primate models. Eventual application in humans with tumor resection cavities that might contain residual tumor cells will also need preclinical determination that a nutrient medium does not promote tumor growth. Preliminary results indicate that regrowth of residual tumor cells is inhibited by several components of Neuregen in culture, in contrast to promotion of growth in serum-containing medium (GJ Brewer and PD LeRoux, unpublished data).
Conclusions
We have shown that cortical aspiration lesions in rats can be treated with an optimized nutrient medium applied with Gelfoam sponges to promote neuropreservation. Four weeks after lesioning, injuries treated with Neuregen show neuron densities adjacent to the lesion almost at the levels observed after sham treatment, and much better than the results of treatment with saline. Overall, neuron densities measured to evaluate treatment effects on the contralateral cortex showed that Neuregen was the most effective and saline the least effective treatment (Neuregen-I plus bFGF Ͼ Neuregen-I Х Neuregen-D Х sham Ͼ saline). Neuregen treatment also reduces gliosis adjacent to the lesion, which should be more permissive for neuroregeneration than saline treatment. These results should encourage further behavioral studies of lesions in the rat motor cortex and spinal cord, as well as future clinical trials with this agent as a candidate to minimize neurodegeneration after craniotomy with tissue resection.
